Related Experiment Video
Updated: May 16, 2025
04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
Inhaled Chemotherapy.
Janakiraman Subramanian1, Rajiv Dhand2
1Inova Schar Cancer Center, Fairfax, VA, USA.
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|April 1, 2025
Summary
Inhaled chemotherapy offers a promising regional treatment for lung cancers, potentially reducing systemic side effects. Current research indicates its feasibility and effectiveness in treating lung tumors.
Area of Science:
- Oncology
- Pulmonology
- Pharmacology
Background:
- Cytotoxic chemotherapy is a standard cancer treatment, often administered systemically with significant adverse effects.
- Regional chemotherapy can minimize systemic exposure and side effects, but is underutilized for lung tumors.
- Inhaled chemotherapy presents a novel regional approach for lung cancer treatment.
Purpose of the Study:
- To review current studies and ongoing trials on inhaled chemotherapy for lung tumors.
- To assess the potential of aerosolized chemotherapy to reduce systemic toxicity.
- To explore the efficacy of inhaled chemotherapy in treating primary and metastatic lung cancer.
Main Methods:
- Review of published preclinical and early-phase human clinical trials.
- Evaluation of aerosol administration of various chemotherapeutic agents.
- Analysis of studies investigating direct arterial absorption and extrapulmonary therapeutic effects.
Main Results:
- Inhaled chemotherapy is feasible and shows effectiveness in treating lung tumors.
- Aerosol administration may mitigate common systemic chemotherapy side effects.
- Some agents demonstrate direct arterial absorption, offering potential extrapulmonary benefits.
Conclusions:
- Inhaled chemotherapy is an emerging regional treatment strategy for lung malignancies.
- Further research and clinical trials are warranted to establish its role in cancer therapy.
- This approach holds promise for improving treatment outcomes and patient quality of life.
Keywords:
Lung canceraerosol targetingchemotherapylung metastasisnonsmall cell lung cancerregional treatmentside effectsMore Related Videos
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
40.5K
05:56Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
659
Related Concept Videos
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
192
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
192
01:23Inhaled Medications
205
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
205
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
144
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
144
01:18Additional Routes of Drug Administration
2.7K
Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
2.7K
01:20Inhalational Anesthetics: Overview
148
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
148
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
161
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
161